Global Hodgkin Lymphoma Treatment Market - Industry Size, Share, Trends and Forecast 2019 - 2025

Published - May 2019 | Category - Pharma & Healthcare | No. of Pages - 117 | Published By - QYR

Table of Contents

Global Hodgkin Lymphoma Treatment Market - Industry Size, Share, Trends and Forecast 2019 - 2025

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Type (2019-2025)
1.3.2 Alocrest
1.3.3 ANK Program
1.3.4 Azacitidine
1.3.5 BMS-986016
1.3.6 BPX-501
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Hodgkin Lymphoma Treatment Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Research Center
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Hodgkin Lymphoma Treatment Market Size
2.1.1 Global Hodgkin Lymphoma Treatment Revenue 2014-2025
2.1.2 Global Hodgkin Lymphoma Treatment Sales 2014-2025
2.2 Hodgkin Lymphoma Treatment Growth Rate by Regions
2.2.1 Global Hodgkin Lymphoma Treatment Sales by Regions 2014-2019
2.2.2 Global Hodgkin Lymphoma Treatment Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Hodgkin Lymphoma Treatment Sales by Manufacturers
3.1.1 Hodgkin Lymphoma Treatment Sales by Manufacturers 2014-2019
3.1.2 Hodgkin Lymphoma Treatment Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Hodgkin Lymphoma Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Hodgkin Lymphoma Treatment Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Hodgkin Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.3 Hodgkin Lymphoma Treatment Price by Manufacturers
3.4 Key Manufacturers Hodgkin Lymphoma Treatment Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Hodgkin Lymphoma Treatment Market
3.6 Key Manufacturers Hodgkin Lymphoma Treatment Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Alocrest Sales and Revenue (2014-2019)
4.1.2 ANK Program Sales and Revenue (2014-2019)
4.1.3 Azacitidine Sales and Revenue (2014-2019)
4.1.4 BMS-986016 Sales and Revenue (2014-2019)
4.1.5 BPX-501 Sales and Revenue (2014-2019)
4.1.6 Others Sales and Revenue (2014-2019)
4.2 Global Hodgkin Lymphoma Treatment Sales Market Share by Type
4.3 Global Hodgkin Lymphoma Treatment Revenue Market Share by Type
4.4 Hodgkin Lymphoma Treatment Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Hodgkin Lymphoma Treatment Sales by Application

6 United States
6.1 United States Hodgkin Lymphoma Treatment Breakdown Data by Company
6.2 United States Hodgkin Lymphoma Treatment Breakdown Data by Type
6.3 United States Hodgkin Lymphoma Treatment Breakdown Data by Application

7 European Union
7.1 European Union Hodgkin Lymphoma Treatment Breakdown Data by Company
7.2 European Union Hodgkin Lymphoma Treatment Breakdown Data by Type
7.3 European Union Hodgkin Lymphoma Treatment Breakdown Data by Application

8 China
8.1 China Hodgkin Lymphoma Treatment Breakdown Data by Company
8.2 China Hodgkin Lymphoma Treatment Breakdown Data by Type
8.3 China Hodgkin Lymphoma Treatment Breakdown Data by Application

9 Rest of World
9.1 Rest of World Hodgkin Lymphoma Treatment Breakdown Data by Company
9.2 Rest of World Hodgkin Lymphoma Treatment Breakdown Data by Type
9.3 Rest of World Hodgkin Lymphoma Treatment Breakdown Data by Application
9.4 Rest of World Hodgkin Lymphoma Treatment Breakdown Data by Countries
9.4.1 Rest of World Hodgkin Lymphoma Treatment Sales by Countries
9.4.2 Rest of World Hodgkin Lymphoma Treatment Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Cell Medica Limited
10.1.1 Cell Medica Limited Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.1.4 Hodgkin Lymphoma Treatment Product Introduction
10.1.5 Cell Medica Limited Recent Development
10.2 Cellular Biomedicine Group, Inc.
10.2.1 Cellular Biomedicine Group, Inc. Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.2.4 Hodgkin Lymphoma Treatment Product Introduction
10.2.5 Cellular Biomedicine Group, Inc. Recent Development
10.3 Constellation Pharmaceuticals, Inc.
10.3.1 Constellation Pharmaceuticals, Inc. Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.3.4 Hodgkin Lymphoma Treatment Product Introduction
10.3.5 Constellation Pharmaceuticals, Inc. Recent Development
10.4 Curis, Inc.
10.4.1 Curis, Inc. Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.4.4 Hodgkin Lymphoma Treatment Product Introduction
10.4.5 Curis, Inc. Recent Development
10.5 Faron Pharmaceuticals Oy
10.5.1 Faron Pharmaceuticals Oy Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.5.4 Hodgkin Lymphoma Treatment Product Introduction
10.5.5 Faron Pharmaceuticals Oy Recent Development
10.6 Fate Therapeutics, Inc.
10.6.1 Fate Therapeutics, Inc. Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.6.4 Hodgkin Lymphoma Treatment Product Introduction
10.6.5 Fate Therapeutics, Inc. Recent Development
10.7 Gamida Cell Ltd.
10.7.1 Gamida Cell Ltd. Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.7.4 Hodgkin Lymphoma Treatment Product Introduction
10.7.5 Gamida Cell Ltd. Recent Development
10.8 Gilead Sciences, Inc.
10.8.1 Gilead Sciences, Inc. Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.8.4 Hodgkin Lymphoma Treatment Product Introduction
10.8.5 Gilead Sciences, Inc. Recent Development
10.9 Incyte Corporation
10.9.1 Incyte Corporation Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.9.4 Hodgkin Lymphoma Treatment Product Introduction
10.9.5 Incyte Corporation Recent Development
10.10 Merck & Co., Inc.
10.10.1 Merck & Co., Inc. Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Hodgkin Lymphoma Treatment
10.10.4 Hodgkin Lymphoma Treatment Product Introduction
10.10.5 Merck & Co., Inc. Recent Development
10.11 Mirati Therapeutics Inc.
10.12 Molecular Templates Inc.
10.13 NantKwest, Inc.

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hodgkin Lymphoma Treatment Sales Channels
11.2.2 Hodgkin Lymphoma Treatment Distributors
11.3 Hodgkin Lymphoma Treatment Customers

12 Market Forecast
12.1 Global Hodgkin Lymphoma Treatment Sales and Revenue Forecast 2019-2025
12.2 Global Hodgkin Lymphoma Treatment Sales Forecast by Type
12.3 Global Hodgkin Lymphoma Treatment Sales Forecast by Application
12.4 Hodgkin Lymphoma Treatment Forecast by Regions
12.4.1 Global Hodgkin Lymphoma Treatment Sales Forecast by Regions 2019-2025
12.4.2 Global Hodgkin Lymphoma Treatment Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 

Quick Buy